Key control
- Johnson & Johnson’s actions fell on Tuesday, after the company said a judge rejected its “pre -starting banking plan” proposed for a subsidiary to solve thousands of claims claiming that its baby dust and other talcum products cause ovarian cancer.
- The company said it will now return to the civil liability system “to litigate and defeat” they affirm them.
- Johnson and Johnson had tried twice before, in 2021 and 2023, use the bankruptcy system to resolve the statements.
The actions of Johnson and Johnson (JNJ) fell on Tuesday after the company said that a judge rejected its “pre -envised bankruptcy plan” proposed for a subsidiary, since part of their last attempt to use a bankruptcy court to solve thousands of claims claiming their baby dust and other talcum products cause ovarian cancer.
Johnson & Johnson’s actions fell around 5% in recent negotiations, among the actions that lead the decreases in the S&P 500.
The company, which for a long time argued that talk -related claims have no merit, he said on Monday that he will now return to the “grievance system to litigate and defeat” the statements and reverse around $ 7 billion that he had reserved to resolve bankruptcy.
“Unfortunately, the court has allowed a couple of law firms with financially conflicting motifs, which have admitted that they have not recovered a penny for their clients in a decade of litigation, to defeat the overwhelming desire of the claimants,” said Erik Haas, world vice president of litigation in Johnson & Johnson.
“The decision to litigate each archived case is based on the simple fact that this is a false claim created by the greedy lawyers looking for another deep pocket to sue and fed by the advertising of lawyers financed by litigation,” he added.
Johnson & Johnson has tried twice before, in 2021 and 2023, use the bankruptcy system to solve the claims.
